Can ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients?

Medical Hypotheses

Volumn 63, Issue 6, 2004, Pages 1018-1023

  Bauer, P O ^a,b   Zumrova, A ^a   Matoska, V ^a   Mitsui, K ^b   Goetz, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 2; DNA; DNA METHYLTRANSFERASE; MUTANT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

DNA METHYLATION; DNA POLYMORPHISM; DNA REPLICATION; DOWN REGULATION; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC VARIABILITY; HUMAN; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA TRANSLATION; SPINOCEREBELLAR DEGENERATION;

ATAXIA;

EID: 7044254730     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.03.046     Document Type: Article

References (60)

1. Evidente V.G., Gwinn-Hardy K.A., Caviness J.N., Gilman S. Hereditary ataxias. Mayo. Clin. Proc. 75(5):2000;475-490
2. Yoo S-Y, Zoghbi HY. Dominantly inherited spinocerebellar syndromes. In: Jones HR, De Vivo DC, Darras BT, editors. Neuromuscular disorders of infancy, childhood, and adolescence: a clinician's approach. Woburn, MA: Butterworth-Heinemann; 2003. p. 1165-1183.
3. Orr H.T., Chung M.Y., Banfi S., et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4(3):1993;221-226
4. Gispert S., Twells R., Orozco G., et al. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat. Genet. 4(3):1993;295-299
5. Kawaguchi Y., Okamoto T., Taniwaki M., et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8(3):1994;221-228
6. Stevanin G., Sousa P.S., Cancel G., et al. The gene for Machado-Joseph disease maps to the same 3-cM interval as the spinal cerebellar ataxia 3 gene on chromosome 14q. Neurobiol. Dis. 1(1-2):1994;79-82
7. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 15(1):1997;62-69
8. Gouw L.G., Kaplan C.D., Haines J.H., et al. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat. Genet. 10(1):1995;89-93
9. Nakamura K., Jeong S.Y., Uchihara T., et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10(14):2001;1441-1448
10. Orozco G., Estrada R., Perry T.L., et al. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J. Neurol. Sci. 93(1):1989;37-50
11. Geschwind D.H., Perlman S., Figueroa C.P., Treiman L.J., Pulst S.M. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am. J. Hum. Genet. 60(4):1997;842-850
12. Lu C.S., WuChou Y.H., Kuo P.C., Chang H.C., Weng Y.H. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch. Neurol. 61(1):2004;35-38
13. Payami H., Nutt J., Gancher S., Bird T., et al. SCA2 may present as levodopa-responsive parkinsonism. Mov. Disord. 18(4):2003;425-429
14. Shan D.E., Soong B.W., Sun C.M., Lee S.J., Liao K.K., Liu R.S. Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann. Neurol. 50(6):2001;812-815
15. Durr A., Smadja D., Cancel G., et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 118(6):1995;1573-1581
16. Cancel G., Durr A., Didierjean O., et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum. Mol. Genet. 6(5):1997;709-715
17. Pulst S.M., Nechiporuk A., Nechiporuk T., et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 14(3):1996;269-276
18. Babovic-Vuksanovic D., Snow K., Patterson M.C., Michels V.V. Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion. Am. J. Med. Genet. 79(5):1998;383-387
19. Mao R., Aylsworth A.S., Potter N., et al. Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. Am. J. Med. Genet. 110(4):2002;338-345
20. Koshy B.T., Zoghbi H.Y. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol. 7(3):1997;927-942
21. Imbert G., Saudou F., Yvert G., et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 14(3):1996;285-291
22. Riess O., Laccone F.A., Gispert S., et al. SCA2 trinucleotide expansion in German SCA patients. Neurogenetics. 1(1):1997;59-64
23. Sanpei K., Takano H., Igarashi S., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 14(3):1996;277-284
24. Chattopadhyay B., Ghosh S., Gangopadhyay P.K., et al. Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India. Neurosci. Lett. 345(2):2003;93-96
25. Hayes S., Turecki G., Brisebois K., et al. CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum. Mol. Genet. 9(12):2000;1753-1758
26. Huynh D.P., Yang H.T., Vakharia H., Nguyen D., Pulst S.M. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum. Mol. Genet. 12(13):2003;1485-1496
27. Huynh D.P., Del Bigio M.R., Ho D.H., Pulst S.M. Expression of ataxin2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Ann. Neurol. 45(2):1999;232-241
28. Koyano S., Uchihara T., Fujigasaki H., Nakamura A., Yagishita S., Iwabuchi K. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci. Lett. 273(2):1999;117-120
29. Pang J.T., Giunti P., Chamberlain S., et al. Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain. 125(Pt 3):2002;656-663
30. Giuffrida S., Lanza S., Restivo D.A., et al. Clinical and molecular analysis of 11 Sicilian SCA2 families: influence of gender on age at onset. Eur. J. Neurol. 6(3):1999;301-307
31. Klockgether T., Ludtke R., Kramer B., et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 121(Pt 4):1998;589-600
32. Nechiporuk T., Huynh D.P., Figueroa K., Sahba S., Nechiporuk A., Pulst S.M. The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression. Hum. Mol. Genet. 7(8):1998;1301-1309
33. Aguiar J., Santurlidis S., Nowok J., et al. Identification of the physiological promoter for spinocerebellar ataxia 2 gene reveals a CpG island for promoter activity situated into the exon 1 of this gene and provides data about the origin of the nonmethylated state of these types of islands. Biochem. Biophys. Res. Commun. 254(2):1999;315-318
34. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science. 293(5532):2001;1068-1070
35. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16(1):2002;6-21
36. Futscher B.W., Oshiro M.M., Wozniak R.J., et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31(2):2002;175-179
37. Strichman-Almashanu L.Z., Lee R.S., Onyango P.O., et al. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 12(4):2002;543-554
38. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:1998;141-196
39. Razin A., Shemer R. DNA methylation in early development. Hum. Mol. Genet. 4(Spec No):1995;1751-1755
40. Sanford J.P., Clark H.J., Chapman V.M., Rossant J. Differences in DNA methylation during oogenesis and spermatogenesis and their persistence during early embryogenesis in the mouse. Genes Dev. 1(10):1987;1039-1046
41. Scrable H., Stambrook P.J. Activation of the lac repressor in the transgenic mouse. Genetics. 147(1):1997;297-304
42. Turker M.S. The establishment and maintenance of DNA methylation patterns in mouse somatic cells. Semin Cancer Biol. 9(5):1999;329-337
43. Carotti D., Funiciello S., Palitti F., Strom R. Influence of pre-existing methylation on the de novo activity of eukaryotic DNA methyltransferase. Biochemistry. 37(4):1998;1101-1108
44. Tollefsbol T.O., Hutchison III C.S. Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase. J. Mol. Biol. 269(4):1997;494-504
45. Lindsay H., Adams L.P. Spreading of methylation along DNA. Biochem. J. 320(pt 2):1996;473-478
46. Toth M., Lichtenberg U., Doerfler W. Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns. Proc. Natl. Acad. Sci. USA. 86(10):1989;3728-3732
47. Howell C.Y., Steptoes A.L., Miller M.W., Chaillet J.R. cis-Acting signal for inheritance of imprinted DNA methylation patterns in the preimplantation mouse embryo. Mol. Cell. Biol. 18(7):1998;4149-4156
48. Turker M.S., Mummaneni P., Bishop P.L. Region and cell type-specific de novo DNA methylation in cultured mammalian cells. Somat. Cell. Mol. Genet. 17(2):1991;151-157
49. Szyf A., Tanigawa G., McCarthy P.L. Jr. A DNA signal from Thy-1 defines de novo methylation patterns in embryonic stem cells. Mol. Cell. Biol. 10(8):1990;4396-4400
50. Leonhardt H., Page A.W., Weirer H.U., Bestor T.H. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell. 71(5):1992;865-873
51. Smith S.S., Kan J.L.C., Baker D.J., Kaplan B.E., Dembek P. Recognition of unusual DNA structures by human DNA (cytosine-5) methyltransferase. J. Mol. Biol. 217(1):1991;39-51
52. Chen X., Mariappan S.V., Catasti P., et al. Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc. Natl. Acad. Sci. USA. 92(11):1995;5199-5203
53. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99(3):1999;247-257
54. Gacy A.M., Goellner G., Juranic N., Macura S., McMurray C.T. Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell. 81(4):1995;533-540
55. Smith G.K., Jie J., Fox G.E., Gao X. DNA CTG triplet repeats involved in dynamic mutations of neurologically related gene sequences form stable duplexes. Nucleic Acids Res. 23(21):1995;4303-4311
56. Yu A., Dill J., Mitas M. The purine-rich trinucleotide repeat sequences d(CAG)15 and d(GAC)15 form hairpins. Nucleic Acids Res. 23(20):1995;4055-4057
57. Mitas M. Trinucleotide repeats associated with human disease. Nucleic Acids Res. 25(12):1997;2245-2254
58. Choudhry S., Mukerji M., Srivastava A.K., Jain S., Brahmachari S.K. CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum. Mol. Genet. 10(21):2001;2437-2446
59. Gabbara S., Bhagwat A.S. The mechanism of inhibition of DNA (cytosine-5-)-methyltransferases by 5-azacytosine is likely to involve methyl transfer to the inhibitor. Biochem. J. 307(Pt1):1995;87-92
60. Santi D.V., Norment A., Garrett C.E. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. Proc. Natl. Acad. Sci. USA. 81(22):1984;6993-6997